The report of an initiative undertaken jointly by the European Medicines Agency (EMA) and the European network for Health Technology Assessment  (EUnetHTA) to make regulators’ reports about scientific assessments of medicines better usable by health technology assessment (HTA) bodies, has been published in Value in Health, the Journal of The International Society For Pharmacoeconomics And Outcomes Research.

The article, entitled “Improving the contribution of regulatory assessment reports to health technology assessments – a collaboration between the European Medicines Agency and the European network for Health Technology Assessment”, is authored by staff members of the EMA and representatives of EUnetHTA. This work was the first joint project between regulators and HTA bodies on a European level and is part of their ongoing dialogue to support policy-maker decisions in the future.

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/06/news_detail_002131.jsp&mid=WC0b01ac058004d5c1